Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Net Margin (2022 - 2026)

Envoy Medical's Net Margin history spans 5 years, with the latest figure at 14617.95% for Q1 2026.

  • On a quarterly basis, Net Margin fell 106143.0% to 14617.95% in Q1 2026 year-over-year; TTM through Mar 2026 was 12020.09%, a 51482.0% increase, with the full-year FY2025 number at 11892.95%, up 53950.0% from a year prior.
  • Net Margin hit 14617.95% in Q1 2026 for Envoy Medical, down from 10316.0% in the prior quarter.
  • Over the last five years, Net Margin for COCH hit a ceiling of 1750.0% in Q3 2023 and a floor of 57385.0% in Q4 2022.
  • Historically, Net Margin has averaged 14704.56% across 5 years, with a median of 13107.14% in 2024.
  • Biggest five-year swings in Net Margin: skyrocketed 5081237bps in 2023 and later tumbled -1485714bps in 2024.
  • Tracing COCH's Net Margin over 5 years: stood at 57385.0% in 2022, then surged by 89bps to 6572.63% in 2023, then plummeted by -178bps to 18300.0% in 2024, then soared by 44bps to 10316.0% in 2025, then plummeted by -42bps to 14617.95% in 2026.
  • Business Quant data shows Net Margin for COCH at 14617.95% in Q1 2026, 10316.0% in Q4 2025, and 18445.24% in Q3 2025.